TRCT
HURA

Tower Research Capital (TRC)’s TuHURA Biosciences HURA Stock Holding History

Tower Research Capital (TRC)’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9K Buy
8,877
+812
+10% +$995 ﹤0.01% 3648
2025
Q4 		$6.1K Buy
8,065
+3,700
+85% +$7.08K ﹤0.01% 4076
2025
Q3 		$10.8K Buy
+4,365
New +$11.5K ﹤0.01% 3949
2024
Q4 		– Sell
-282
Closed -$1.92K – 6085
2024
Q3 		$1.92K Buy
282
+232
+464% +$1.73K ﹤0.01% 5082
2024
Q2 		$468 Sell
50
-473
-90% -$2.94K ﹤0.01% 5320
2024
Q1 		$1.9K Buy
523
+384
+276% +$1.54K ﹤0.01% 5160
2023
Q4 		$825 Buy
139
+94
+209% +$4.86K ﹤0.01% 5490
2023
Q3 		$6.33K Sell
45
-91
-67% -$13.4K ﹤0.01% 4615
2023
Q2 		$19.3K Buy
136
+85
+167% +$9.67K ﹤0.01% 3417
2023
Q1 		$6K Buy
51
+35
+219% +$6.75K ﹤0.01% 4900
2022
Q4 		$4K Sell
16
-1
-6% -$222 ﹤0.01% 5089
2022
Q3 		$3K Sell
17
-2
-11% -$639 ﹤0.01% 5446
2022
Q2 		$9K Buy
19
+11
+138% +$4.79K ﹤0.01% 4598
2022
Q1 		$6K Buy
+8
New +$5.76K ﹤0.01% 4946
2021
Q3 		– Sell
-2
Closed -$7K – 6253
2021
Q2 		$7K Buy
+2
New +$5.75K ﹤0.01% 4574
2021
Q1 		– Sell
-5
Closed -$10K – 5790
2020
Q4 		$10K Buy
5
+4
+400% +$10K ﹤0.01% 4330
2020
Q3 		$3K Buy
+1
New +$2.01K ﹤0.01% 4539
2017
Q1 		– Hold
0
– -$1K – 4038
2016
Q4 		– Hold
0
– – – 3672
2016
Q3 		– Hold
0
– – – 2590

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Tower Research Capital (TRC)'s HURA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its TuHURA Biosciences (HURA) stake by 10% in Q1 2026, buying an estimated $995 and bringing the position to 8,877 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

Tower Research Capital (TRC) first reported a position in HURA in Q3 2020 and has held it in 17 quarters since. The position peaked at $19.3K in Q2 2023. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Tower Research Capital (TRC) held 8,877 shares of TuHURA Biosciences worth $15.9K as of Q1 2026.
  • Tower Research Capital (TRC) bought 812 TuHURA Biosciences shares in Q1 2026, an estimated $995.
  • TuHURA Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3648 holding.
  • Tower Research Capital (TRC) first reported a position in TuHURA Biosciences in Q3 2020 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s TuHURA Biosciences position peaked at $19.3K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.